update in revenue profile from acadia downgrade and timing effects.
- Forums
- ASX - By Stock
- Neuren Media and Analyst Coverage
update in revenue profile from acadia downgrade and timing...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.98 |
Change
-0.255(1.57%) |
Mkt cap ! $2.034B |
Open | High | Low | Value | Volume |
$16.33 | $16.37 | $15.87 | $4.127M | 257.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 114 | $15.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.99 | 202 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 502 | 15.980 |
5 | 379 | 15.970 |
4 | 292 | 15.960 |
3 | 236 | 15.950 |
4 | 362 | 15.940 |
Price($) | Vol. | No. |
---|---|---|
16.000 | 249 | 5 |
16.010 | 226 | 6 |
16.020 | 269 | 3 |
16.030 | 300 | 3 |
16.040 | 239 | 3 |
Last trade - 11.04am 13/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online